Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
- Hagen Cramer, PhD - Chief Technology Officer, QurAlis
Workshop will cover the following topics:
The workshop will provide insight into decisions made to enable a multi-product facility that can accept many oligonucleotide types/designs and scales, all the while ensuring proper alignment of large scale and downscale processes. Critical Quality Attributes are suspected to influence efficacy, safety, and quality of final products, therefore consideration of CQAs for large scale manufacturing will be discussed. Participants will gain an insight into Large Scale manufacturing of oligonucleotide API and to the design of a facility. Major themes of the workshop will include:
- Large Scale Manufacturing: Challenges and Solutions
- Designing a Facility: Challenges and Solutions
- Critical Quality Attributes (CQA): How to Maintain during Upscaling
Who should attend?
Anyone interested in understanding the challenges that might exist if oligonucleotide manufacturing were to be build-up in-house rather than depending on a CDMO. Manufacturing personnel, quality assurance (QA), and project management (PM) would realize the most benefit out of this workshop.
- Thomas Rupp - Managing Director, Axolabs Berlin GmbH
- Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
- Hagen Cramer, PhD - Chief Technology Officer, QurAlis
- Bruce Morimoto, PhD - Vice President, Drug Development, Alto Neuroscience
- Robert Hagopian - Director Business Development, PolyPeptide Group
- Robert Hagopian - Director Business Development, PolyPeptide Group
- Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
- Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
- Yogesh Sanghvi, PhD - President, Rasayan Inc.
- Hiroaki Suga, PhD - Professor of Chemistry, School of Science, University of Tokyo, Japan
- Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
- Tamar Grossman, PhD - VP, Global Head of RNA, Gene Therapy and Delivery, Johnson & Johnson Innovative Medicine
- David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
- Tomaz Einfalt, PhD - Principal Investigator II xRNA, Novartis Institutes for BioMedical Research
- Grzegorz Sienski, PhD - Director and Project Leader, AstraZeneca